awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36892821-FBB45406-4109-46F5-ADD8-3761EC2587D1
Q36892821-FBB45406-4109-46F5-ADD8-3761EC2587D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36892821-FBB45406-4109-46F5-ADD8-3761EC2587D1
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.
P921
Q36892821-FBB45406-4109-46F5-ADD8-3761EC2587D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36892821-FBB45406-4109-46F5-ADD8-3761EC2587D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0723282bb80042897ca697416c050b4bf7fb5428
P921
bevacizumab